Active Biotech's Renal Cancer Project ANYARA Featured in Journal of Immunotherapy - Marketwire (press release) Print
Marketwire (press release)ANYARA is presently in development for the treatment of renal cell cancer. A phase III study, which has completed enrollment of over 500 patients,

... read more